Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01669746 · ClinicalTrials.gov registry record · Phase 2

A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)

A Phase 2 study, sponsored by Aderans Research Institute.

Completed
Registry status
Phase 2
Development phase
34
Enrollment target

NCT01669746: Completed Phase 2 study, sponsored by Aderans Research Institute.

NCT01669746 is a Phase 2 study that has completed, run by Aderans Research Institute. The registered enrollment target is 34 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01669746, a Phase 2 study, has completed, sponsored by Aderans Research Institute.

COMPLETED
Registry status
Phase 2
Development phase
34 participants
Enrollment target

Study Summary

Evaluate the ability of injections of Ji Gami(TM) CN to induce hair growth in male and female subjects with hair loss.

Interventions

  • BIOLOGICAL Autologous cultured mixed population of dermal cells

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2012-06
Phase Phase 2
Aderans Research Institute

11 total trials

What the finished NCT01669746 record still lists

NCT01669746 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower).

The record links to 0 conditions, and to 1 intervention - of which Autologous cultured mixed population of dermal cells is the first listed.

NCT01669746 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01669746 about?

NCT01669746 is a clinical study titled "A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)". Evaluate the ability of injections of Ji Gami(TM) CN to induce hair growth in male and female subjects with hair loss.

What is the current status of trial NCT01669746?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2012-06.

What interventions are being tested in trial NCT01669746?

The interventions under investigation include: Autologous cultured mixed population of dermal cells (BIOLOGICAL).

Who is sponsoring clinical trial NCT01669746?

This trial is sponsored by Aderans Research Institute, which has 11 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01669746's enrollment target sits among peer trials

34 1539th of 2000 higher than 448 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01669746, the US trial registry maintained by the National Library of Medicine. NCT01669746 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.